Short-Term Efficacy of Vedolizumab in Patients With Inflammatory Bowel Disease in Real-Life Settings in Bosnia and Herzegovina. Biomol Biomed 2024, 24 (5), 1400–1406. https://doi.org/10.17305/bb.2024.10433.